Form D · Other Health Care
CycloSam Therapeutics, LLC
Angleton, TX · CIK 0001695653
Offering snapshot reported Jan 27, 2017 · SEC filing
- Reported sold
- $200K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $200K Reported outside-investor minimum
- First sale
- Jan 23, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 27, 2017 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-279442
Source: Form D, filed Jan 27, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen R Ellebracht | Director |
| R Keith Frank | Director, Executive, Promoter |
| Joseph P Rybak | Director |
| Jaime Simon | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1004 S. Velasco Street
Angleton, TX, 77515
Angleton, TX, 77515